Get started
Author

Anica Högner

Observed names: A. Högner, Anica Hoegner, Högner, Anica
ORCID: 0000-0001-6083-6449
Observed ORCID: 0000-0001-6083-6449
OpenAlex ID: A5041389851
Immunotherapy in Gastric Cancer
2022 · Anica Högner, Markus Moehler · Current Oncology · 177
PDF
Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinoma
2022 · Markus Moehler, Anica Högner, et al. · European Journal of Cancer · 47
PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient’s overall survival
2017 · Anica Högner, Hans Krause, et al. · Urologic Oncology Seminars and Original Investigations · 39
Myoglobin facilitates angiotensin II-induced constriction of renal afferent arterioles
2017 · Z. Z. Liu, S. Mathia, et al. · American Journal of Physiology-Renal Physiology · 34
Immune Checkpoint Inhibition in Oesophago-Gastric Carcinoma
2021 · Anica Högner, Peter Thuss-Patience · Pharmaceuticals · 28
PDF
Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase‐II study—The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO ‐0510
2021 · Anica Högner, Salah‐Eddin Al‐Batran, et al. · International Journal of Cancer · 22
PDF
The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus
2016 · Ergin Kilic, Pierre Tennstedt, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 16
Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma
2024 · Peter Thuss-Patience, Anica Högner, et al. · JAMA Network Open · 15
PDF
Diagnostic and Prognostic Potential of MicroRNA Maturation Regulators Drosha, AGO1 and AGO2 in Urothelial Carcinomas of the Bladder
2018 · Anja Rabien, Nadine Ratert, et al. · International Journal of Molecular Sciences · 8
PDF
RAP: A phase II trial with ramucirumab, avelumab, and paclitaxel as second line treatment in gastro-esophageal adenocarcinoma of the arbeitsgemeinschaft internistische onkologie (AIO).
2019 · Anica Högner, Kirstin Breithaupt, et al. · Journal of Clinical Oncology · 7
Ramucirumab, avelumab, and paclitaxel (RAP) as second-line treatment in gastro-esophageal adenocarcinoma, a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
2022 · Peter C. Thuss-Patience, Anica Högner, et al. · Journal of Clinical Oncology · 5
Impact of Postoperative Chemotherapy in Patients with Gastric/Gastroesophageal Adenocarcinoma Treated with Perioperative Chemotherapy
2022 · Alexej Ballhausen, Prisca Bartels, et al. · Current Oncology · 5
PDF
Prognostic Relevance of Weight and Weight Loss during Multimodal Therapy for Oesophagogastric Tumours
2022 · Alessandro Lorusso, Dmitry Bichev, et al. · Current Oncology · 4
PDF
High expectations: from treatment to prevention
2015 · M. Ludwig, A. Högner · Acta Physiologica · 3
PDF
Immunotherapy as a new perspective for the therapy of esophageal cancer
2024 · Yvonne Huber, Markus Moehler, et al. · Innovative Surgical Sciences · 1
PDF
You are not alone
2016 · M. Ludwig, A. Högner, et al. · Acta Physiologica · 1
PDF
Ramucirumab, avelumab and paclitaxel (RAP) as second line treatment in esophagogastric adenocarcinoma: Final results of the phase 2 RAP trial (AIO-STO-0218).
2023 · Peter C. Thuss-Patience, Anica Högner, et al. · Journal of Clinical Oncology
Neue Entwicklungen in der Immuntherapie des Ösophagus- und Magenkarzinoms
2022 · Anica Högner, Peter Thuss-Patience · TumorDiagnostik & Therapie
Systemtherapie des Ösophaguskarzinoms
2020 · Alexej Ballhausen, Prisca Bartels, et al. · TumorDiagnostik & Therapie
Feasibility and effects of home parenteral nutrition (HPN) in cancer patients with or without migrant background.
2020 · Lena Rebekka Schickhaus, Anica Högner, et al. · Journal of Clinical Oncology
Abstract 3181: Expression changes of the chromatin modifier PBRM1 in human renal cell carcinomas in relation to histopathological features
2016 · Hans Krause, Anica Högner, et al. · Cancer Research
Abstract LB-88: The role of PBRM1 as tumor suppressor gene in renal cell carcinomas
2014 · Burkhard Jandrig, Odiljon Ikromov, et al. · Cancer Research
Works count: 23
Citation count: 412
H-index: 8
I10-index: 8
Year
Topic
Type